On-Demand EditCo Symposium: Uncovering Novel Cancer Therapeutic Targets: Accelerating Discovery Through Streamlined CRISPR Cell Engineering

Title: Uncovering Novel Cancer Therapeutic Targets: Accelerating Discovery Through Streamlined CRISPR Cell Engineering

This on-demand symposium during EACR 2025 features thought leaders in molecular oncology, gene editing, and computational biology, highlighting how CRISPR technologies are transforming cancer research.

Session Overview:

• Dr. Simon Lebaron, Centre de Biologie Intégrative, University of Toulouse
  Unveiling SURF2’s Role in Nucleolar Stress and Its Potential as a Therapeutic Target

  Related Case Study:

  Rapid, Reliable Knockouts for Cancer Biology with XDel Technology: Unveiling SURF2’s Role in Nucleolar Stress and Its Potential as a Therapeutic Target

• Dr. Daniel Miller, Evariste
  AI-Driven Identification and Validation of Novel Synthetic Lethal Gene Pairs

• Dr. Amalia Soenens, EditCo Bio
  Leveraging an Advanced CRISPR Platform to Streamline Oncology Breakthroughs